Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
Mizuno, Takaaki; Kojima, Yuki; Yonemori, Kan; Yoshida, Hiroshi; Sugiura, Yukiko; Ohtake, Yohei; Okuma, Hitomi S; Nishikawa, Tadaaki; Tanioka, Maki; Sudo, Kazuki; Shimomura, Akihiko; Noguchi, Emi; Kato, Tomoyasu; Shimoi, Tatsunori; Uno, Masaya; Ishikawa, Mitsuya; Fujiwara, Yasuhiro; Ohe, Yuichiro; Tamura, Kenji.
Afiliación
  • Mizuno T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Kojima Y; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
  • Yonemori K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Yoshida H; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Sugiura Y; Department of Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ohtake Y; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Okuma HS; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Nishikawa T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Tanioka M; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Sudo K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Noguchi E; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Kato T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Shimoi T; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Uno M; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Fujiwara Y; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ohe Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Tamura K; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
Oncol Lett ; 20(6): 336, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33123247
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: Japón